Xalatan

In some countries, this medicine may only be approved for veterinary use.

In the US, Xalatan (latanoprost ophthalmic) is a member of the drug class ophthalmic glaucoma agents and is used to treat Glaucoma - Open Angle and Intraocular Hypertension.

US matches:

• Xalatan


• Xalatan Drops


• Xalatan Multi-Pack

UK matches:

• Xalatan 0.005% eye drops solution (SPC)

Ingredient matches for Xalatan

Latanoprost

Latanoprost is reported as an ingredient of Xalatan in the following countries:

• Argentina


• Australia


• Austria


• Belgium


• Benin


• Bosnia & Herzegowina


• Burkina Faso


• Cameroon


• Canada


• Central African Republic


• Chad


• Chile


• China


• Colombia


• Congo


• Costa Rica


• Cote D'ivoire


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Ecuador


• El Salvador


• Estonia


• Finland


• France


• Gabon


• Georgia


• Germany


• Greece


• Guatemala


• Guinea


• Honduras


• Hong Kong


• Hungary


• Iceland


• Indonesia


• Ireland


• Israel


• Italy


• Japan


• Latvia


• Lithuania


• Madagascar


• Malaysia


• Mali


• Malta


• Mauritania


• Mauritius


• Mexico


• Netherlands


• New Zealand


• Nicaragua


• Niger


• Norway


• Oman


• Panama


• Peru


• Philippines


• Poland


• Portugal


• Romania


• Russian Federation


• Senegal


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Taiwan


• Thailand


• Togo


• Tunisia


• Turkey


• United Kingdom


• United States


• Venezuela


• Zaire

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.